The intensifying debate over pharmacy benefits managers could ... consumers would likely pay more for their drugs at the ...
Pharmacy benefit managers CVS Caremark, OptumRx and Express Scripts inflated costs for specialty generic drugs to treat diseases such as cancer and HIV to the tune of $7.3 billion over six years ...
Zydus Lifesciences reacted sharply to the development in Tuesday's trade with the counter rising 5.23 percent to an intraday high of Rs 1,011.75 per share on the NSE.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback